An update on autophagy disorders
- PMID: 39420677
- PMCID: PMC11669743
- DOI: 10.1002/jimd.12798
An update on autophagy disorders
Abstract
Macroautophagy is a highly conserved cellular pathway for the degradation and recycling of defective cargo including proteins, organelles, and macromolecular complexes. As autophagy is particularly relevant for cellular homeostasis in post-mitotic tissues, congenital disorders of autophagy, due to monogenic defects in key autophagy genes, share a common "clinical signature" including neurodevelopmental, neurodegenerative, and neuromuscular features, as well as variable abnormalities of the eyes, skin, heart, bones, immune cells, and other organ systems, depending on the expression pattern and the specific function of the defective proteins. Since the clinical and genetic resolution of EPG5-related Vici syndrome, the paradigmatic congenital disorder of autophagy, the widespread use of massively parallel sequencing has resulted in the identification of a growing number of autophagy-associated disease genes, encoding members of the core autophagy machinery as well as related proteins. Recently identified monogenic disorders linking selective autophagy, vesicular trafficking, and other pathways have further expanded the molecular and phenotypical spectrum of congenital disorders of autophagy as a clinical disease spectrum. Moreover, significant advances in basic research have enhanced the understanding of the underlying pathophysiology as a basis for therapy development. Here, we review (i) autophagy in the context of other intracellular trafficking pathways; (ii) the main congenital disorders of autophagy and their typical clinico-pathological signatures; and (iii) the recommended primary health surveillance in monogenic disorders of autophagy based on available evidence. We further discuss recently identified molecular mechanisms that inform the current understanding of autophagy in health and disease, as well as perspectives on future therapeutic approaches.
Keywords: autophagy; cellular trafficking; congenital disorders; neurodegeneration; neurodevelopment.
© 2024 The Author(s). Journal of Inherited Metabolic Disease published by John Wiley & Sons Ltd on behalf of SSIEM.
Conflict of interest statement
The authors have no conflicts of interests.
Figures


References
-
- Dionisi Vici C, Sabetta G, Gambarara M, et al. Agenesis of the corpus callosum, combined immunodeficiency, bilateral cataract, and hypopigmentation in two brothers. Am J Med Genet. 1988;29:1‐8. - PubMed
-
- Deneubourg C, Ramm M, Smith LJ. The spectrum of neurodevelopmental, neuromuscular and neurodegenerative disorders due to defective autophagy. Autophagy. 2022;18:496‐517. https://pubmed.ncbi.nlm.nih.gov/39082157/ - PMC - PubMed
Publication types
MeSH terms
Supplementary concepts
Grants and funding
- 371/2021/Koeln Fortune Program/Faculty of Medicine, University of Cologne
- P50 HD105351/HD/NICHD NIH HHS/United States
- 413543196/Cologne Clinician Scientist Program/Medical Faculty/University of Cologne and German Research Foundation
- 765912-DRIVE-H2020-MSCA-ITN-2017/European Union Horizon 2020 Programme
- 243/2022/Koeln Fortune Program/Faculty of Medicine, University of Cologne
LinkOut - more resources
Full Text Sources
Research Materials